An expert explains the necessity of managing patients’ testosterone levels while treating prostate cancer. When treating patients with prostate cancer, controlling testosterone levels in the body is ...
Nubeqa (darolutamide) received FDA approval for metastatic castration-sensitive prostate cancer, showing significant improvement in radiographic progression-free survival. The ARANOTE trial involved ...
Radiographic progression without PSA progression in metastatic hormone-sensitive prostate cancer (mHSPC): A retrospective analysis from the ENZAMET trial (ANZUP 1304). This is an ASCO Meeting Abstract ...
In the extensive catalogue of cruelty that humans have inflicted on others, castration surely occupies a special place, not least because permanent sterilization is the outcome. As in all other male ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results